Tag #Ezetimibe

What factors currently hinder the widespread adoption of this combined drug therapy, and what are the potential consequences of inaction?

The study analyzed data from 36,000 Swedish heart attack patients (2015-2022), comparing outcomes for those receiving statins and ezetimibe within 12 weeks versus later or statins alone. Patients receiving the combined treatment early had a considerably better prognosis and lower risk of further events. This demonstrates a clear link between timely, combined medication and improved patient outcomes.